Cresilon, Inc. — Form D
Cresilon, Inc. of BROOKLYN, NY, a company, filed a Form D exempt-offering notice with the SEC on 2021-02-16. The offering totals $45.3M, of which $24.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-02-16
- Form: D
- Accession: 0001728054-21-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $45.3M
- Amount sold: $24.5M
- Remaining: $20.8M
- Minimum investment: $25K
- Investors: 170
- Date of first sale: 2021-01-29
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-389442
Issuer
- Name: Cresilon, Inc.
- CIK: 0001728054
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 122 18TH STREET Suite 6-3-D, BROOKLYN, NY, 11215
- Phone: (347) 435-2226
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Scott Levine | Executive Officer | Brooklyn, NY |
| Scott Levine | Related Person | Brooklyn, NY |
| Isaac Miller | Director | Brooklyn, NY |
| Isaac Miller | Executive Officer | Brooklyn, NY |
| Isaac Miller | Related Person | Brooklyn, NY |
| Joseph Landolina | Director | Brooklyn, NY |
| Joseph Landolina | Executive Officer | Brooklyn, NY |
| Joseph Landolina | Related Person | Brooklyn, NY |
Other filings by this issuer (8)
More